Therefore future work should focus on taking specific inhibitors of PDE7B from the autoimmune studies and determining their efficacy in blocking glioma growth in vitro and in vivo with the hope of translating these findings to the clinic as quickly as possible. The gene discussed is PDE7B; the disease is central nervous system cancer.